[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Carlos L. Arteaga<\/i><\/u><\/presenter>. UT Southwestern Simmons Comp. Cancer Center, Dallas, TX","CSlideId":"","ControlKey":"fdb9eec1-1c31-4a65-8acf-f71acde37616","ControlNumber":"10390","DisclosureBlock":"<b>&nbsp;C. L. Arteaga, <\/b> <br><b>AstraZeneca<\/b> I. <br><b>Athenex Pharmaceutical Division, LLC<\/b> I. <br><b>Daiichi Sankyo Company<\/b> I. <br><b>Eli Lilly and Company<\/b> I, G. <br><b>Immunomedics, Inc.<\/b> I. <br><b>Laboratorios Pfizer Ltda.<\/b> G. <br><b>Merck<\/b> I. <br><b>Novartis<\/b> I. <br><b>SANOFI PASTEUR INC.<\/b> I. <br><b>Susan G. Komen for the Cure<\/b> I. <br><b>Taiho Oncology, Inc.<\/b> I. <br><b>Takeda Oncology<\/b> G.","End":"4\/17\/2023 7:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"9172","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Carlos Arteaga, MD","PresenterKey":"007d021b-7d9a-49e9-a921-a56a6f3c7705","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Resistance to endocrine therapy in breast cancer","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  7:00AM","SessionId":"626","SessionOnDemand":"False","SessionTitle":"Resistance to Endocrine Therapy in Breast Cancer","ShowChatLink":"false","Start":"4\/17\/2023 7:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Resistance to endocrine therapy in breast cancer","Topics":null,"cSlideId":""}]